Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study

BMJ. 2006 Aug 5;333(7562):281. doi: 10.1136/bmj.38834.421713.2F. Epub 2006 Jun 23.

Abstract

Objective: To determine the incidence of methicillin resistant and methicillin sensitive Staphylococcus aureus (MRSA and MSSA) bacteraemia in inpatients and associated mortality within 30 days after diagnosis.

Design: Anonymised record linkage study of data from hospital information systems and microbiology databases.

Setting: Teaching hospital and district general hospital in Oxfordshire.

Participants: Inpatients aged 18 or over admitted to a teaching hospital between 1 April 1997 and 31 March 2004 and to a district general hospital between 1 April 1999 and 31 March 2004. The main part of the study comprised 216 644 inpatients; patients admitted to haematology, nephrology, or oncology services were not included because most were managed as outpatients.

Outcome measures: Nosocomial MSSA and MRSA bacteraemia; death in hospital within 30 days after bacteraemia.

Results: Rates of S aureus bacteraemia rose between 1997 and 2003, and MRSA was responsible for this increase. Overall mortality 30 days after bacteraemia was 29%. The crude odds ratio for death after MRSA bacteraemia compared with MSSA bacteraemia was 1.49 (95% confidence interval 0.99 to 2.26).

Conclusion: The spread of MRSA has greatly increased the overall number of cases of S aureus bacteraemia and has contributed to short term mortality after S aureus bacteraemia.

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Bacteremia / drug therapy
  • Bacteremia / mortality
  • Cohort Studies
  • Cross Infection
  • England / epidemiology
  • Hospital Mortality*
  • Hospitals, District
  • Hospitals, General
  • Hospitals, Teaching
  • Humans
  • Incidence
  • Length of Stay
  • Methicillin / therapeutic use*
  • Methicillin Resistance*
  • Middle Aged
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / mortality*
  • Staphylococcus aureus*

Substances

  • Anti-Bacterial Agents
  • Methicillin